eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
1/2016
vol. 2
 
Share:
Send email
Share:
abstract:
Review paper

Hepatology topics of special interest from Central Europe (Czech Republic, Hungary, Poland, Slovakia)

Bela Hunyady
,
Jerzy Jaroszewicz
,
Ľubomír Lipták
,
Ľubomír Skladaný
,
Jan Sperl
,
Juraj Šváč

Clinical and Experimental HEPATOLOGY 2016; 1: 16–20
DOI: https://doi.org/10.5114/ceh.2016.58852
Online publish date: 2016/03/24
View full text Get citation
 
PlumX metrics:
This compilation represents abstracts of presentations at the first meeting of the Initiative Group for the Central European Hepatologic Collaboration (CEHC, Warsaw, 19-21 November, 2015) on topics with special interest from four Central European countries and includes a summary of a boceprevir-based triple therapy cohort programme (from Hungary), current trends and challenges in liver diseases (from Poland), acute kidney injury in liver cirrhosis (from Slovakia) and treatment of hepatitis C in haemodialysed patients (from the Czech Republic). All these topics are or have been of high interest during the last several years, and many of them are still not completely resolved with the emergence and availability of the novel interferon-free therapies for hepatitis C and with other advances in the pathophysiology and treatment of liver diseases.
keywords:

boceprevir, direct acting antiviral drug, hepatitis C virus, interferon, kidney injury
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.